Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

NCT06706284 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Spinal Cord Injuries
Type 2 Diabetes

Interventions

DRUG: Semaglutide Injectable Product
OTHER: Placebo

Sponsor

Marzieh Salehi

Collaborators

[object Object]